Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. Although many efforts for treating HCC have been made, the survival rate remains unsatisfied. Accumulating evidence indicates that microRNA-218 (miR-218) functions as a tumor suppressor and involves in many biological processes such as tumor initiation, development, and metastasis in certain types of human cancers. However, the potential function and underlying molecular mechanism of miR-218 in HCC still remains to be elucidated. Since HCC is a genetic disease, exploring the mechanisms of the pathogeny and integration are essential for the discovery of novel treatment targets for HCC. Therefore, the aim of the present study was to investigate the abnormal expression level of miR-218 in clinical HCC tissues and HCC cells, and to evaluate its function and underlying mechanisms in HCC. Our results revealed that miR-218 expression was significantly downregulated in HCC tissues and cell lines. Gain-of-function and loss-of-function assays indicated that forced expression of miR-218 in HCC cells inhibited cell migration/invasion and reversed epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET), while deletion of miR-218 promoted cell migration/invasion and contributed to the EMT phenotype formation. Bioinformatics analysis and luciferase reporter assay confirmed that serpine mRNA binding protein 1 (SERBP1) was a target gene of miR-218 and rescue assay further confirmed that SERBP1 involved in the function of miR-218 in HCC. All these results suggested that miR-218/SERBP1 signal pathway could inhibit the malignant phenotype formation and that targeting this pathway may be a potential novel way for HCC therapeutics.
Introduction
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide [1] . With the characteristics of invasion, metastasis, and frequent recurrence, HCC accounts for 70%-90% of primary liver cancer and has been a major health problem worldwide [2, 3] . Although the development of treating HCC has been made currently, the prognosis of HCC still remains unsatisfied. The initial and progression of HCC involves the dysregulation of many genes. Thus, lucubrating the underlying mechanism of the initial and progression of HCC is critical for exploring novel treatment targets of HCC.
MicroRNAs (miRNAs), a class of endogenous non-coding RNAs of 19-25 nt, are able to silence gene expression by direct binding to the 3′-untranslated region (3′-UTR) of messenger RNAs (mRNAs) and inhibiting protein translation in diverse biological and pathological processes [4] . Accumulating documents have depicted that dysregulation of miRNAs was involved in the initial and progression of many cancers like HCC, colorectal cancer, breast cancer, cervical cancer, ovarian cancer, and non-small cell lung cancer [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . MicroRNA-218 (miR-218) has been demonstrated to be an anti-oncogene in osteosarcoma cancer, glioma cancer, pancreatic cancer, gallbladder cancer, prostate cancer, cervical cancer, and HCC [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . However, the function of miR-218 in epithelial-mesenchymal transition (EMT) formation of HCC cells has not been elucidated.
In the present study, we found that miR-218 was downregulated in HCC tissues and HCC cells. The restoration of miR-218 was suggested to inhibit cell metastasis and reverse the EMT phenotype. Additionally, serpine mRNA binding protein 1 (SERBP1) was identified as a target of miR-218 by bioinformatics analysis and luciferase reporter assays. We also provided evidence that miR-218 suppresses the metastasis and EMT of HCC cells probably through directly targeting SERBP1.
Materials and Methods

Patients
HCC tissues (n = 32) and pair-matched noncancerous tissues were obtained through tissue biopsy from patients diagnosed with HCC at the Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine (Shanghai, China) from 2013 to 2016. And the tissues were divided into three groups: high-differentiation (n = 9), moderate-differentiation (n = 12), and low-differentiation (n = 11) according to the histological grades. Informed consents were obtained from all patients.
Cell lines
Four HCC cell lines (SMMC-7721, Bel-7402, HepG2, and Hep3B), and a normal liver epithelium cell line (L02) were purchased from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, Carlsbad, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin in humidified air at 37°C with 5% CO 2 .
Cell transfection
pcDNA3.1/SERBP1 (pcDNA3.1 as control) and miR-218 mimics and inhibitor were purchased from Applied Biological Materials (ABM, Vancouver, Canada). Transfections were performed using the Lipofectamine 2000 kit (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions.
Real-time quantitative reverse-transcription polymerase chain reaction
Total RNA from tissues and cells was isolated with Trizol reagent (Invitrogen) according to the manufacturer's instructions. Reverse transcription was performed with PrimeScript™RT Master Mix for mRNA (Cat. No. RR036A; Takara, Dalian, China) and Mir-X™ miRNA FirstStrand Synthesis for miRNA (Cat. Nos. 638313; Takara) according to the manufacturer's protocol. Real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was performed with SYBR Prime Script RT-PCR Kit (Takara) based on the manufacturer's instructions. The levels of miR-218 and SERBP1 were calculated with the 2 −ΔΔCt method, which was normalized to u6 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), respectively. All assays were performed in triplicate. The expression levels were relative to the fold change of the corresponding controls, which were defined as 1.0.
Wound healing assay
Cell migration capacity was measured by wound healing assay. In brief, 2 × 10 5 cells with or without transfection were seeded into wells of 12-well plates and incubated in DMEM with 10% FBS at 37°C. After cell cultures reached 100% confluence, cells were wounded by scraping with a 200 μl tip, followed by three times wash with serumfree medium, and then incubated in regular medium. Wounds were observed at 0 and 48 h. The cell migration distance was calculated by subtracting the wound width at each time point from the wound width at the 0 h time point. Three independent assays were performed.
Cell migration and invasion assays
Cell migration/invasion was detected by transwell assay using Corning transwell chambers with 8-μm pore size (Corning Co, Corning, USA) with/without Matrigel. At 48 h after transfection, 4 × 10 3 cells in serum-free media were placed into the upper chamber, while medium containing 10% FBS was added into the lower chamber. After 48 h of incubation, cells remaining in upper membrane were wiped off, and cells that had migrated were fixed in methanol, and stained with 0.1% crystal violet. Cells were counted under a microscope. Three independent experiments were carried out.
Cell attachment and detachment assays
For attachment assay, cells were seeded into wells of 24-well plates at 5 × 10 4 cells per well. Unattached cells were removed after 1 h of incubation, and the attached cells were counted after trypsinization. The data were presented as a percentage of the attached cells compared with total cells. For cell detachment assay, after 24 h incubation, the cells were incubated with 0.05% trypsin for 3 min to detach the cells. Then, the culture medium was added to inactivate the trypsin and the detached cells were collected. The remaining cells were incubated with 0.25% trypsin to detach and counted. The data were presented as a percentage of the detached cells to total cells. Three independent experiments were carried out.
Dual luciferase reporter assay
pmirGLO-SERBP1-wt and pmirGLO-SERBP1-mut (miR-218) were co-transfected with miR-218 mimics or miRNA negative control (NC) into HEK293 cells by lipofectamine-mediated gene transfer. The relative luciferase activity was normalized to renilla luciferase activity 48 h after transfection. The data were relative to the fold change of the corresponding control groups defined as 1.0.
Western bolt analysis
Total protein lysates were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and were electrophoretically transferred to polyvinylidene difluoride membranes (Roche, Basel, Switzerland). Protein loading was estimated using mouse anti-GAPDH monoclonal antibody. The membranes were blocked with 10% non-fat milk in Tris-buffered saline and Tween 20 for 2 h at room temperature, washed and then probed with the rabbit antihuman SERBP1 antibody ( , and mouse anti-GAPDH monoclonal antibody (1:3000 dilution, Abcam) overnight at 4°C, followed by incubation with the corresponding horseradish peroxidase-conjugated secondary antibody for 2 h at room temperature. The blots were finally detected using an enhanced chemiluminescence system (Thermo, Waltham, USA) and exposed to X-ray film.
Immunofluorescence
Cells seeded on glass coverslips in six-well plates were fixed with 4% formaldehyde solution and permeabilized with 0.5% Triton X-100/phosphate buffered saline (PBS). Fixed cells were blocked with 5% bovine serum albumin/PBS for 1 h at room temperature and incubated with primary antibodies (anti-E-cadherin antibody and anti-N-cadherin antibody) at 4°C overnight, followed by incubation with fluorescent-dye conjugated secondary antibody (Invitrogen) for 1 h, and then stained with DAPI. Finally, images were taken under an inverted fluorescence microscope.
Statistical analysis
Data are shown as the mean ± standard error of at least three independent experiments. The SPSS 17.0 software (SPSS Inc., Chicago, USA) was used for statistical analysis. Two group comparisons were performed with independent samples t-test or Student's t-test. Multiple group comparisons were analyzed with one-way ANOVA. Statistically significant positive correlation between miR-218 and SERBP1 expression levels in 32 cases of HCC tissues was analyzed by Spearman's correlation analysis. Statistically significant negative correlation between miR-218 and SERBP1 expression levels in 32 cases of HCC tissues was analyzed by Spearman's correlation analysis. All tests performed were two-sided. P < 0.05 was considered of statistically significant difference.
Results
miR-218 is downregulated in HCC tissues and cancer cells
In order to investigate the function and mechanism of miR-218 in HCC, qRT-PCR was first employed to measure the miR-218 expression in 32 pairs of HCC tissues and corresponding normal tissues. Compared with the matched noncancerous tissue, miR-218 levels were significantly decreased in cancerous tissues (P < 0.01) (Fig. 1A) .
Then, the level of miR-218 was compared among histological grades. As shown in Fig. 1B , the level of miR-218 was consistent with the histological grates. Furthermore, the level of miR-218 was examined in four HCC cell lines (SMMC-7721, Bel-7402, HepG2, and Hep3B), and a normal liver epithelium cell line (L02). As shown in Fig. 1C , the level of miR-218 in HCC was decreased except for HepG2 cells; the level of miR-218 in SMMC-7721 cells was the lowest; and the level of miR-218 in HepG2 cells was almost the same as that of normal liver epithelium cell line L02. These results indicated that miR-218 might be involved in the progression of HCC.
Downregulated miR-218 contributes to the metastasis and EMT formation of HCC cells
To investigate the effect of miR-218 on proliferation, metastasis, and EMT of HCC cells, SMMC-7721 cells or HepG2 cells were transfected with miR-218 mimics or inhibitor, respectively, using miR-NC or anti-miR-NC as negative control. Satisfactory transfection efficiency was observed at 48 h post-transfection ( Fig. 2A , P < 0.01). Results from MTT and colony formation revealed that miR-218 has no significant effect on cell proliferation ability ( Supplementary Fig. S1 ). As shown in The level of miR-218 in four HCC cell lines (SMMC-7721, Bel-7402, HepG2, and Hep3B) and a normal liver epithelial cell line (L02). Data are presented as the mean ± SD of at least three independent experiments. N.S., not significant; *P < 0.05, **P < 0.01 vs. control group. HCC, hepatocellular carcinoma; miR-218, microRNA-218; qRT-PCR, real-time quantitative reverse-transcription polymerase chain reaction. miR-218 regulates HCC through SERBP1 immunofluorescence assay (Fig. 2F) showed that increased level of epithelial markers (E-cadherin) and decreased level of mesenchymal markers (N-cadherin) were observed in cells transfected with miR-218 mimics, and the opposite result was obtained in cells transfected with miR-218 inhibitor. These data indicated that miR-218 might be involved in the metastasis and EMT formation of HCC cells.
SERBP1 is a target of miR-218
Overexpression of SERBP1 has been found to be involved in many tumor biological processes. To explore whether SERBP1 is involved in the function of miR-218, the level of SERBP1 was first detected in four HCC cell lines (SMMC-7721, Bel-7402, HepG2, and Hep3B), as well as in the normal liver epithelium cell line (L02), and the results showed that the SERBP1 was significantly up-regulated in these HCC cell lines (Fig. 3A) . In addition, we employed two bioinformatics analysis websites (http://www.targetscan.org/cgi-bin/ targetscan/vert_61/view_gene.cgi?taxid=9606&rs=NM_001083588 &members=&showcnc=0&shownc=0&showncf= and http:// mirdb.org/cgi-bin/target_detail.cgi?targetID=1804872) to predict the binding site and performed luciferase reporter assay to confirm the regulation relationship between miR-218 and SERBP1. As shown in Fig. 3B , the 3′-UTR of SERBP1 contains a binding site for miR-218, and miR-218 mimics could reduce the luciferase activity of the wildtype SERBP1 reporter vector (WT) rather than the mutant reporter vector (MUT). Additionally, results from qRT-PCR and western blot showed that overexpression of miR-218 reduced both the mRNA and protein level of SERBP1, and downexpression of miR-218 increased both the mRNA and protein level of SERBP1 (Fig. 3C) . The results above suggest that SERBP1 is a bona fide miR-218-targeting gene.
SERBP1 positively regulates EMT phenotype of HCC cells
Although miR-218 could bind to the 3′-UTR of SERBP1 and regulate the expression of SERBP1, the function of SERBP1 in HCC should be confirmed. SMMC-7721 and HepG2 cells were transfected with sh-SERBP1 (sh-RNA as control) and pcDNA3.1/ SERBP1 (NC as control), respectively. Satisfactory transfection efficiency was obtained after 48 h post-transfection (Fig. 4A) . As observed in Fig. 4B -D, wound healing, transwell, and attachment/ detachment assays showed that downregulated SERBP1 significantly suppressed cell metastasis, and on the contrary, cells transfected with SERBP1 presented an increased metastasis capacity. Additionally, the function of SERBP1 on EMT formation of HCC cells was confirmed by western blot analysis and immunofluorescence assay. As shown in Fig. 4E ,F, downregulated SERBP1 in SMMC-7721 cells increased the level of epithelial markers and decreased the level of mesenchymal markers, and opposite results were obtained in SERBP1-overexpressing HepG2 cells. Therefore, these data together indicate that the function of miR-218 is at least partially mediated by SERBP1.
The function of miR-218 in HCC cells is dependent on SERBP1
To further confirm that the role of miR-218 played in HCC is mediated by SERBP1, rescue assays were performed. SMMC-7721 cells were transfected with empty vector, miR-218 mimics, and pcDNA3.1/SERBP1. As shown in Fig. 5A -C, wound healing, transwell, and attachment/detachment assays revealed that metastasis capacity was increased in cells co-transfected with miR-218 mimics and pcDNA3.1/SERBP1, compared with the miR-218 mimics group. Furthermore, results from western blot analysis and immunofluorescence assay showed that the high level of epithelial markers and low expression of mesenchymal markers induced by miR-218 mimics of SMMC-7721 cells could be partially reversed by co-transfection with SERBP1 ( Fig. 5D,E) . These data together suggest that deletion of miR-218 could contribute to the metastasis and EMT phenotype formation in HCC cells and such function may be mediated by SERBP1.
SERBP1 is up-regulated in HCC tissues and has negative correlation with the level of miR-218
Finally, the level of SERBP1 was examined in 32 HCC tumor tissue samples. As shown in Fig. 6A , the expression level of SERBP1 in the tumor tissue samples was significantly higher than that in the corresponding histologically normal tissues (P < 0.01). Furthermore, the level of SERBP1 was negatively correlated with the level of miR-218 expression level (two-tailed Spearman's correlation, r = −0.903, P < 0.01; Fig. 6B ). These findings suggest that down-regulation of miR-218 facilitates the metastasis and EMT formation of HCC cells partially through targeting SERBP1. 
Discussion
Accumulating evidence showed that abnormal expression of miRNAs is associated with the progression of various cancers [31] [32] [33] . The present study showed that miR-218 expression is significantly decreased in human HCC tissues and HCC cells. SERBP1 is identified as a target of miR-218 and is negatively regulated by miR-218 at the posttranscriptional level, via a specific target site within the 3′-UTR of SERBP1. Previous studies have reported that miR-218 could inhibit cell proliferation, migration/invasion and EMT via targeting downstream genes. For example, Wang et al. [17] reported that miR-218 inhibits the proliferation, migration, and EMT of gastric cancer cells by targeting WASF3; Wang et al. [18] demonstrated that miR-218 inhibits the proliferation, migration, and invasion and promotes the apoptosis of gastric cancer cells by targeting LASP1; Jiang et al. [34] identified that miR-218 inhibits EMT, migration, and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer; and Wang et al. [35] showed that miR-218 modulates the viability of renal cell carcinoma by regulating BCL9. Moreover, miR-218 also could interact with lncRNA. Lu et al. [36] demonstrated that epigenetic silencing of miR-218 by the lncRNA CCAT1, acting via BMI1, promotes an altered cell cycle transition in the malignant transformation of HBE cells induced by cigarette smoke extract. However, the expression and the potential biological function of miR-218 in HCC cells have not been fully elucidated.
It is well known that miRNA exerts its biological function by regulating target genes [37] . We employed two bioinformatics analysis websites to predict the binding sites between miR-218 and SERBP1. SERBP1 was first reported in epithelial ovarian cancer, and it is also involved in the progression of breast cancer, colon cancer, and prostate cancer [38] [39] [40] . In our study, we characterized SERBP1 as a functional target of miR-218 by luciferase reporter gene assays, qRT-PCR, and western blot analysis, respectively. Furthermore, we also found that the level of SERBP1 was significantly increased in HCC tissues and was negatively correlated with miR-218 expression in HCC tissues. Additionally, deletion of SERBP1 could mimic the function of miR-228 in HCC cells. These data together indicate that miR-218 suppresses the metastasis and EMT of HCC cells through directly targeting SERBP1.
In summary, we first demonstrated that the expression of miR-218 in HCC tissues and HCC cells was significantly lower than that in the corresponding normal tissues and normal liver epithelial cell. Moreover, overexpression of miR-218 could significantly suppress cell metastasis, and reverse EMT to mesenchymal-epithelial transition. MiR-218 may be exert this function through targeting SERBP1. This regulatory pathway provides novel insight into the mechanisms underlying the progression and development of HCC, which may be a potential therapeutic strategy to treat HCC.
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